Klinik und Diagnostik von chronischen Immunneuropathien

Lernziele

Kenntnisse über

Einteilung chronischer Immunneuropathien Epidemiologie, Diagnostik und Therapie der chronisch-inflammatorischen demyelinisierenden Polyneuropathie multifokalen motorischen Neuropathie subakuten sensiblen Neuronopathie Denny-Brown vaskulitischen Neuropathien

Literatur

• 1 Stamboulis E, Katsaros N, Koutsis G. et al . Clinical and subclinical autonomic dysfunction in chronic inflammatory demyelinating polyradiculoneuropathy.  Muscle Nerve. 2006;  33 78-84
• 2 Noronha A B, Harper J R, Ilyas A A. et al . Myelin-associated glycoprotein shares an antigenic determinant with a glycoprotein of human melanoma cells.  J Neurochem. 1986;  47 1558-1565
• 3 Tsuchida T, Saxton R E, Morton D L. et al . Gangliosides of human melanoma.  Cancer. 1989;  63 1166-1174
• 4 Saperstein D S, Katz J S, Amato A A. et al . Clinical spectrum of chronic acquired demyelinating polyneuropathies.  Muscle Nerve. 2001;  24 311-324
• 5 Koller H, Kieseier B C, Jander S. et al . Chronic inflammatory demyelinating polyneuropathy.  N Engl J Med. 2005;  352 1343-1356
• 6 Hughes R A, Donofrio P, Bril V. et al . Intravenous immune globulin (10 % caprylate-chromatography purified) for the treatment of chronic inflammatory demyelinating polyradiculoneuropathy (ICE study): a randomised placebo-controlled trial.  Lancet Neurol. 2008;  7 136-144
• 7 Stangel M, Hartung H P, Gold R. et al . [The significance of intravenous immunoglobulin in treatment of immune-mediated polyneuropathies].  Nervenarzt. 2009;  80 678-687
• 8 Hughes R A, Bouche P, Cornblath D R. et al . European Federation of Neurological Societies / Peripheral Nerve Society guideline on management of chronic inflammatory demyelinating polyradiculoneuropathy: report of a joint task force of the European Federation of Neurological Societies and the Peripheral Nerve Society.  Eur J Neurol. 2006;  13 326-332
• 9 Bril V, Katzberg H, Donofrio P. et al . Electrophysiology in chronic inflammatory demyelinating polyneuropathy with IGIV.  Muscle Nerve. 2009;  39 448-455
• 10 Nobile-Orazio E. Multifocal motor neuropathy.  J Neuroimmunol. 2001;  115 4-18
• 11 Nobile-Orazio E, Cappellari A, Priori A. Multifocal motor neuropathy: current concepts and controversies.  Muscle Nerve. 2005;  31 663-680
• 12 Kaji R, Shibasaki H, Kimura J. Multifocal demyelinating motor neuropathy: cranial nerve involvement and immunoglobulin therapy.  Neurology. 1992;  42 506-509
• 13 Sumner A J. Separating motor neuron diseases from pure motor neuropathies. Multifocal motor neuropathy with persistent conduction block.  Adv Neurol. 1991;  56 399-403
• 14 Lange D J, Trojaborg W, McDonald T D. et al . Persistent and transient „conduction block” in motor neuron diseases.  Muscle Nerve. 1993;  16 896-903
• 15 Jaspert A, Claus D, Grehl H. et al . Multifocal motor neuropathy: clinical and electrophysiological findings.  J Neurol. 1996;  243 684-692
• 16 Katz J S, Wolfe G I, Bryan W W. et al . Electrophysiologic findings in multifocal motor neuropathy.  Neurology. 1997;  48 700-707
• 17 Cornblath D R, Sumner A J. Conduction block in neuropathies with necrotizing vasculitis.  Muscle Nerve. 1991;  14 185-186
• 18 Van Es H W, Van den Berg L H, Franssen H. et al . Magnetic resonance imaging of the brachial plexus in patients with multifocal motor neuropathy.  Neurology. 1997;  48 1218-1224
• 19 Pestronk A, Cornblath D R, Ilyas A A. et al . A treatable multifocal motor neuropathy with antibodies to GM1 ganglioside.  Ann Neurol. 1988;  24 73-78
• 20 Sadiq S A, Thomas F P, Kilidireas K. et al . The spectrum of neurologic disease associated with anti-GM1 antibodies.  Neurology. 1990;  40 1067-1072
• 21 Lamb N L, Patten B M. Clinical correlations of anti-GM1 antibodies in amyotrophic lateral sclerosis and neuropathies.  Muscle Nerve. 1991;  14 1021-1027
• 22 Van den Berg-Vos R M, Franssen H, Wokke J H. et al . Multifocal motor neuropathy: diagnostic criteria that predict the response to immunoglobulin treatment.  Ann Neurol. 2000;  48 919-926
• 23 Taylor B V, Gross L, Windebank A J. The sensitivity and specificity of anti-GM1 antibody testing.  Neurology. 1996;  47 951-955
• 24 Van den Berg L H, Lokhorst H, Wokke J H. Pulsed high-dose dexamethasone is not effective in patients with multifocal motor neuropathy.  Neurology. 1997;  48 1135
• 25 Lehmann H C, Hoffmann F R, Fusshoeller A. et al . The clinical value of therapeutic plasma exchange in multifocal motor neuropathy.  J Neurol Sci. 2008;  271 34-39
• 26 Meucci N, Cappellari A, Barbieri S. et al . Long term effect of intravenous immunoglobulins and oral cyclophosphamide in multifocal motor neuropathy.  J Neurol Neurosurg Psychiatry. 1997;  63 765-769
• 27 van Schaik I N, Bouche P, Illa I. et al . European Federation of Neurological Societies / Peripheral Nerve Society guideline on management of multifocal motor neuropathy.  Eur J Neurol. 2006;  13 802-808
• 28 Honnorat J, Antoine J C. Paraneoplastic neurological syndromes.  Orphanet J Rare Dis. 2007;  2 22
• 29 Graus F, Delattre J Y, Antoine J C. et al . Recommended diagnostic criteria for paraneoplastic neurological syndromes.  J Neurol Neurosurg Psychiatry. 2004;  75 1135-1140
• 30 Camdessanche J P, Antoine J C, Honnorat J. et al . Paraneoplastic peripheral neuropathy associated with anti-Hu antibodies. A clinical and electrophysiological study of 20 patients.  Brain. 2002;  125 166-175
• 31 Antoine J C, Mosnier J F, Absi L. et al . Carcinoma associated paraneoplastic peripheral neuropathies in patients with and without anti-onconeural antibodies.  J Neurol Neurosurg Psychiatry. 1999;  67 7-14
• 32 Keime-Guibert F, Graus F, Fleury A. et al . Treatment of paraneoplastic neurological syndromes with antineuronal antibodies (Anti-Hu, anti-Yo) with a combination of immunoglobulins, cyclophosphamide, and methylprednisolone.  J Neurol Neurosurg Psychiatry. 2000;  68 479-482
• 33 Izquierdo J RC, Kissel J T. Vasculitic neuropathies. San Diego; Med Link Corporation 2007
• 34 Said G. Vasculitic neuropathy.  Curr Opin Neurol. 1999;  12 627-629
• 35 Nadeau S E. Diagnostic approach to central and peripheral nervous system vasculitis.  Neurol Clin. 1997;  15 759-777
• 36 de Groot K, Gross W L, Hellmich B. [Therapy of primary systemic vasculitis].  Internist (Berl). 2003;  44 1541-1548
• 37 de Groot K, Rasmussen N, Bacon P A. et al . Randomized trial of cyclophosphamide versus methotrexate for induction of remission in early systemic antineutrophil cytoplasmic antibody-associated vasculitis.  Arthritis Rheum. 2005;  52 2461-2469
• 38 Gold R, Toyka K V. Immuntherapie neurologischer Krankheiten. Bremen; Uni-Med Verlag AG 2007
• 39 Kissel J T, Mendell J R. Vasculitic neuropathy.  Neurol Clin. 1992;  10 761-781
• 40 Collins M P, Periquet M I, Mendell J R. et al . Nonsystemic vasculitic neuropathy: insights from a clinical cohort.  Neurology. 2003;  61 623-630
• 41 Collins M P, Periquet M I. Non-systemic vasculitic neuropathy.  Curr Opin Neurol. 2004;  17 587-598
• 42 Meuth S G, Kleinschnitz C. Multifocal motor neuropathy: update on clinical characteristics, pathophysiological concepts and therapeutic options.  Eur. Neurol;  63 193-204
• 43 European Federation of Neurological Societies / Peripheral Nerve Society Guideline on management of multifocal motor neuropathy. Report of a joint task force of the European Federation of Neurological Societies and the Peripheral Nerve Society.  J Peripher Nerv Syst. 2006;  11 1-8